Coeptis Therapeutics (COEPW) Competitors

$0.02

+0.01 (+46.30%)

(As of 07/26/2024 ET)

Stock Analysis Chart Competitors Financials SEC Filings Trends

COEPW vs. ATNFW, SXTPW, DRTSW, APLMW, BCDAW, BCTXW, CDIOW, CTCXW, SAVAW, and CELUW

Should you be buying Coeptis Therapeutics stock or one of its competitors? The main competitors of Coeptis Therapeutics include 180 Life Sciences (ATNFW), 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), BioCardia (BCDAW), BriaCell Therapeutics (BCTXW), Cardio Diagnostics (CDIOW), Carmell (CTCXW), Cassava Sciences (SAVAW), and Celularity (CELUW). These companies are all part of the "biotechnology" industry.

Coeptis Therapeutics vs.

180 Life Sciences (NASDAQ:ATNFW) and Coeptis Therapeutics (NASDAQ:COEPW) are both medical companies, but which is the better business? We will contrast the two businesses based on the strength of their earnings, community ranking, profitability, risk, institutional ownership, valuation, dividends, analyst recommendations and media sentiment.

: Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio
180 Life Sciences N/A N/A N/A N/A N/A
Coeptis Therapeutics N/A N/A N/A N/A N/A
: Company Net Margins Return on Equity Return on Assets
180 Life Sciences N/A N/A N/A
Coeptis Therapeutics N/A N/A N/A
: Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
180 Life Sciences
0 Sell rating(s)
0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A
Coeptis Therapeutics
0 Sell rating(s)

0 Hold rating(s)

0 Buy rating(s)

0 Strong Buy rating(s)
N/A
: 180 Life Sciences and Coeptis Therapeutics both received 0 outperform votes by MarketBeat users.
Company Underperform Outperform
180 Life Sciences N/A N/A
Coeptis Therapeutics N/A N/A
: In the previous week, 180 Life Sciences and 180 Life Sciences both had 1 articles in the media. Coeptis Therapeutics' average media sentiment score of 1.89 beat 180 Life Sciences' score of 1.87 indicating that 180 Life Sciences is being referred to more favorably in the media.
Company Overall Sentiment
180 Life Sciences Very Positive
Coeptis Therapeutics Very Positive

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
180 Life Sciences	N/A	N/A	N/A	N/A	N/A
Coeptis Therapeutics	N/A	N/A	N/A	N/A	N/A

Company	Net Margins	Return on Equity	Return on Assets
180 Life Sciences	N/A	N/A	N/A
Coeptis Therapeutics	N/A	N/A	N/A

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
180 Life Sciences	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A
Coeptis Therapeutics	0 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	N/A

Company	Underperform	Outperform
180 Life Sciences	N/A	N/A
Coeptis Therapeutics	N/A	N/A

Company	Overall Sentiment
180 Life Sciences	Very Positive
Coeptis Therapeutics	Very Positive

Summary

180 Life Sciences beats Coeptis Therapeutics on 1 of the 1 factors compared between the two stocks.

Ad Crypto 101 Media

Brace Yourself: Experts calling for Bitcoin to hit $100k

For the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range. But that could change soon. Very soon.

Click here to get The Crypto Bull Run Millionaire Blueprint now.

Get Coeptis Therapeutics News Delivered to You Automatically

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

COEPW vs. The Competition

Export to Excel

Metric	Coeptis Therapeutics	Biotechnology Industry	Medical Sector	NASDAQ Exchange
Market Cap	N/A	$167.21M	$5.29B	$8.23B
Dividend Yield	N/A	3.43%	2.80%	3.96%
P/E Ratio	N/A	254.03	132.36	15.68
Price / Sales	N/A	15,745.82	2,042.38	80.08
Price / Cash	N/A	11.45	35.22	34.13
Price / Book	N/A	6.55	4.94	4.50
Net Income	N/A	-$18.89M	$111.19M	$216.46M
7 Day Performance	N/A	2.26%	2.52%	1.46%
1 Month Performance	N/A	5.85%	11.07%	7.55%
1 Year Performance	N/A	10.09%	9.55%	2.73%

Coeptis Therapeutics Competitors List

Export to Excel

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	Employee Count	Indicator(s)
ATNFW 180 Life Sciences	0 of 5 stars 0.00 / 5 stars	$0.01 +0.9%	N/A	+8.8%	$0.00	N/A	4
SXTPW 60 Degrees Pharmaceuticals	0 of 5 stars 0.00 / 5 stars	$0.07 +1.6%	N/A	-84.9%	$0.00	$352,864.00	2	Gap Down High Trading Volume
DRTSW Alpha Tau Medical	0 of 5 stars 0.00 / 5 stars	$0.23 -9.8%	N/A	-38.9%	$0.00	N/A	121
APLMW Apollomics	0 of 5 stars 0.00 / 5 stars	$0.01 +10.0%	N/A	-81.3%	$0.00	N/A	59	Gap Down
BCDAW BioCardia	0 of 5 stars 0.00 / 5 stars	$0.01 flat	N/A	N/A	$0.00	$468,000.00	16
BCTXW BriaCell Therapeutics	0 of 5 stars 0.00 / 5 stars	$0.17 +12.4%	N/A	-91.7%	$0.00	N/A	16	Short Interest ↓ High Trading Volume
CDIOW Cardio Diagnostics	0 of 5 stars 0.00 / 5 stars	$0.05 +8.2%	N/A	N/A	$0.00	$32,993.00	7	Gap Down
CTCXW Carmell	0 of 5 stars 0.00 / 5 stars	$0.09 -2.9%	N/A	N/A	$0.00	$3.73M	9	Gap Down
SAVAW Cassava Sciences	0 of 5 stars 0.00 / 5 stars	$0.03 -76.1%	N/A	N/A	$0.00	N/A	30	Gap Up High Trading Volume
CELUW Celularity	0 of 5 stars 0.00 / 5 stars	$0.02 -10.1%	N/A	-74.6%	$0.00	$14.79M	225	Short Interest ↑